Morgan Stanley Inclusive & Sustainable Ventures Announces 2026 Global Cohort of Innovators
14.9.2026 16:00:00 EEST | Business Wire | Press release
Morgan Stanley (NYSE: MS) today announced the 2026 global cohort of its Inclusive & Sustainable Ventures (MSISV). This year’s cohort includes 20 startups and four nonprofits across the Americas and Europe, the Middle East and Africa (EMEA) participating in the firm's five-month accelerator program designed to help early-stage innovators develop and scale their impact.
Selected from thousands of applications, the 24 organizations will receive a $150,000 equity investment, or grant funding for nonprofits, as well as access to a curated curriculum, networking opportunities and office space. Founders will work closely with a dedicated MSISV team, Entrepreneurs in Residence and senior Morgan Stanley mentors. Following the five-month accelerator program, the cohort will present at a global showcase and demo day in February 2027.
MSISV is focused on advancing solutions in four thematic areas where the firm sees significant potential for scale and measurable impact: Environment, Health & Wellbeing, Economic Empowerment and Education & Human Capital.
“Morgan Stanley Inclusive & Sustainable Ventures is helping companies and nonprofits build stronger organizations and advance solutions with the potential for lasting impact,” said Jessica Alsford, Chief Sustainability Officer, Morgan Stanley. “By connecting early-stage innovators with valuable expertise and networking across our Integrated Firm, we can support the unique priorities and long-term growth goals of these game-changing organizations.”
Participants of the 2026 MSISV cohort are:
- Environment: ADAR Technologies (US), Aquagga (US), Concular (Germany), Enerdrape (Switzerland), Everimpact (France), Grale (Sweden), PulpaTronics (UK)
- Health & Wellbeing: Exobiosphere (US), Oxford Heartbeat (UK), Phaeosynt (Germany), Stride (UK), William Oak Diagnostics (UK), Xtory (US)
- Economic Empowerment: ABALOBI (South Africa), Kahawa 1893 (US), Starlight (US), VETLIFE (US), Viva Benefits (US), XENA Intelligence (US)
- Education & Human Capital: AnnieCannons (US), Gratia (US), Robo Wunderkind (US), Social Cipher (US), The Unconnected Foundation (UK)
MSISV has distributed more than $40 million in capital to over 160 organizations since 2017.
Learn more about the 2026 MSISV cohort here.
Learn more about Morgan Stanley Inclusive & Sustainable Ventures here.
About Morgan Stanley Inclusive & Sustainable Ventures
Morgan Stanley Inclusive & Sustainable Ventures (MSISV) provides innovators with access to capital and resources to help them develop and scale. Our mission is to catalyze innovation and impact by supporting early-stage startups and nonprofits that are building solutions for a more inclusive and sustainable future.
About Morgan Stanley
Morgan Stanley is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services. With offices in 42 countries, the Firm’s employees serve clients worldwide including corporations, governments, institutions and individuals. For further information about Morgan Stanley, please visit https://www.morganstanley.com.
This material was published in September 2026 and has been prepared for informational purposes only and is not a solicitation of any offer to buy or sell any security or other financial instrument or to participate in any trading strategy. This material was not prepared by the Morgan Stanley Research Department and is not a Research Report as defined under FINRA regulations. This material does not provide individually tailored investment advice. It has been prepared without regard to the individual financial circumstances and objectives of persons who receive it.
Certain portfolios may include investment holdings that integrate one or more sustainability factors (referred to as "sustainable investments"). Sustainability refers to the integration of certain environmental and/or social considerations into economic, strategic, and business decisions. While individual activities will be evaluated as appropriate on a case-by-case basis, Morgan Stanley’s sustainability efforts generally entail the integration of the following considerations: Climate / Carbon Emissions, Ethics & Business Conduct, Supply Chains, Climate, Environmental and Social Risk Management, Financial & Economic Inclusion, Workforce (including wellness and inclusion practices), Community Engagement, Human Rights, Shareholder Engagement, Corruption & Bribery, Nature and Biodiversity, and Waste.
You should carefully review an investment product’s prospectus or other offering documents, disclosures and/or marketing material to learn more about how it incorporates sustainability factors into its investment strategy.
Sustainability considerations may include, but are not limited to, environmental factors (e.g., climate change, biodiversity), social factors (e.g., human capital, data privacy, diversity & inclusion), and governance factors (e.g., board oversight, business ethics, risk management). You should carefully review an investment product's prospectus or other offering documents, disclosures and/or marketing material to learn more about how it incorporates sustainability factors into its investment strategy.
Sustainable investments may also be referred to as impact aware investments, socially responsible investments, Environmental, Social and Governance ("ESG") investments, or diversity and inclusion ("D&I") investments. It is important to understand that sustainability definitions and criteria used within the industry can vary, and ESG ratings of the same subject companies and/or securities can vary among different ESG ratings providers for several reasons including, differences in definitions, methodologies, processes, data sources and subjectivity among ESG rating providers when determining a rating. Certain issuers of investments including, but not limited to, separately managed accounts ("SMAs"), mutual funds and exchange traded funds ("ETFs") may have differing and inconsistent views concerning sustainability criteria, and the sustainability claims made in offering documents or other literature may overstate sustainability impact. As a result, it is difficult to compare sustainable investment products. Further, socially responsible norms vary by region, and an issuer's sustainability practices or Morgan Stanley's assessment of an issuer's sustainability practices can change over time.
Portfolios that include investment holdings deemed sustainable investments or that employ sustainability screening criteria as part of an overall strategy may experience performance that is lower or higher than a portfolio not employing such practices. Portfolios with sustainability restrictions and strategies as well as sustainable investments may not be able to take advantage of the same opportunities or market trends as portfolios where sustainability criteria are not applied. There is no assurance that a sustainable investing strategy or technique employed will be successful. Past performance is not a guarantee or a dependable measure of future results. For risks related to a specific fund, please refer to the fund's prospectus or summary prospectus.
Investment managers can have different approaches to sustainability and can offer strategies that differ from the strategies offered by other investment managers with respect to the same theme or topic. Additionally, when evaluating investments, an investment manager is dependent upon information and data that may be incomplete, inaccurate, or unavailable, which could cause the manager to incorrectly assess an investment's sustainability characteristics or performance. Such data or information may be obtained through voluntary or third-party reporting. Morgan Stanley does not verify that such information and data is accurate and makes no representation or warranty as to its accuracy, timeliness, or completeness when evaluating an issuer.
Morgan Stanley's assessment of an issuer's sustainability practices or a sustainability portfolio is as of the date of this material. No assurance is provided that the underlying assets have maintained or will maintain any applicable sustainability designations or any stated sustainability compliance, or that the underlying assets have been operated or will be operated in a sustainability-compliant manner. The sustainability impacts of the securities and any underlying assets may vary over time.
This can cause Morgan Stanley to incorrectly assess an issuer's business practices with respect to its sustainability practices. As a result, it is difficult to compare sustainable investment products.
Morgan Stanley makes no representation as to the compliance of any fund or portfolio with any laws or regulatory guidelines, recommendations, requirements or similar standards relating to sustainability; or in connection with or to meet any of your investing sustainability objectives, metrics, or criteria; or otherwise.
The appropriateness of a particular sustainable investment or strategy will depend on an investor's individual circumstances and objectives. Principal value and return of an investment will fluctuate with changes in market conditions.
© 2026 Morgan Stanley & Co. LLC and Morgan Stanley Smith Barney LLC. Members SIPC. All rights reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260914376830/en/
Contacts
Media Relations Contact: Carrie Hall, carrie.hall@morganstanley.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 115.10.2026 03:30:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK)announced today that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (NT1), providing first access to clinicians to prescribe treatment with the new class of medicine. ORZEYFUL is a first-in-class orexin receptor 2 (OX2R) agonist, in tablet form, designed to treat the underlying orexin deficiency associated with NT1. “We’re excited at the potential to fundamentally change how NT1 is managed across Japan and China,” said Giles Platford, president, International, Takeda. “We’ve heard from patients how ORZEYFUL has improved their daily functioning and quality of life, enormously meaningful outcomes for a condition known to impact many aspects of a person’s life, including work, education and social interactions.”1,2,3,4,5 NT1 is a chronic, rare neurological disease driven by orexin deficiency. People experience a range of symptoms including excessive daytime sleepiness, cataplexy (sudden loss of muscle tone), disr
Celltrion to Spotlight Subcutaneous (SC) Infliximab (Remsima™ SC) and Broader IBD Portfolio at UEG Week 202615.10.2026 03:10:00 EEST | Press release
Celltrion, Inc. (KRX:068270) announced its participation in United European Gastroenterology (UEG) Week 2026, in Barcelona, Spain (Oct. 17-20), highlighting its inflammatory bowel disease (IBD) treatment portfolio, led by Remsima™ SC (subcutaneous infliximab). Celltrion will showcase its comprehensive infliximab portfolio, comprising Remsima™ intravenous (IV) and subcutaneous (SC) formulations, as well as the Remsima™ IV liquid formulation launched in Europe earlier this year.1 Additionally, the company will highlight its broader IBD portfolio, including SteQeyma™ (ustekinumab) and Yuflyma™ (adalimumab), reflecting its continued efforts to expand treatment options for patients with IBD.2,3 On October 18, Celltrion will host a symposium titled "Navigating the Treatment Journey with Subcutaneous Infliximab Across Clinical Scenarios," Chaired by Professor Peter M. Irving of King's College London, UK, a leading IBD expert. Celltrion will also host two MTE sessions at its booth. In the firs
ProcureTEX Returns for Its Second Year, Bringing AI and Best-of-Breed Procurement Technology to Amsterdam14.10.2026 19:26:00 EEST | Press release
ProcureTEX, the community-driven event for best-of-breed procurement technology, returns for its second year on November 3, 2026, at Circa in Amsterdam. Following its London debut in 2025, the event sharpens its focus on how AI is reshaping procurement. It will bring together over 250 procurement leaders and digital transformation teams from large enterprises, with vetted best-of-breed technology providers, to see AI agents and interoperable tools working together on real enterprise challenges. Co-founded by Beroe, Keelvar and Zip, the event is built on the belief that the future of procurement isn’t a monolithic all-in-one suite, but an ecosystem of best-of-breed tools working together. It is designed for procurement and enterprise leaders seeking scalable, modern solutions, whether they’re driving transformation, frustrated with outdated tools, or looking to connect with peers solving similar problems and putting AI to work. Renowned technology analyst and former Andreessen Horowitz
eM Client 11 Launches: A European Outlook Alternative Bringing AI Freedom, Digital Sovereignty, and Next-Generation Productivity14.10.2026 19:16:00 EEST | Press release
eM Client, the European developer of the popular email and productivity application used by millions worldwide, today announced the release of eM Client 11, its most significant update yet. The new version introduces advanced AI capabilities, and major productivity improvements, strengthening its position as an independent alternative to Microsoft Outlook. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014945464/en/ eM Client 11 main window AI Without Vendor Lock-In eM Client 11 introduces a powerful AI Assistant that enables users to search, summarize, organize, and manage emails using natural language. Additional features include personalized AI writing, context-aware quick replies, automatic task and event detection, and AI-powered email rules. Unlike traditional AI integrations, eM Client 11 supports Bring Your Own Key (BYOK), allowing organizations to connect compatible AI providers and models of their choice. The re
iQmetrix and Stratus HR Partner to Give Wireless Retailers a Complete, Outsourced HR Department14.10.2026 18:15:00 EEST | Press release
Stratus HR, a full-service human resources outsourcing provider, today announced a partnership with iQmetrix, the Intelligent Commerce Operating System for telecom. As a Professional Employer Organization (PEO), Stratus HR becomes the complete, outsourced HR partner for wireless retailers on iQmetrix – payroll, benefits, compliance, and on-call HR experts – so retail teams stay focused on selling and serving customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014178512/en/ Fully integrated with iQmetrix, Stratus HR’s custom-built technology connects the employee lifecycle to the store: new hires, terminations, rehires, position moves, and security-role updates flow straight into the point of sale (POS), while hours flow from the retailer’s iQmetrix system into payroll – eliminating double entry and pay errors, so every paycheck is accurate and every new hire hits the floor faster. Frontline teams get enterprise-leve
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom